Dicot AB (XSAT:DICOT) Additional Paid-In Capital : kr180.76 Mil(As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dicot AB Additional Paid-In Capital?

Dicot AB's quarterly additional paid-in capital increased from Sep. 2023 (kr166.52 Mil) to Dec. 2023 (kr180.76 Mil) but then stayed the same from Dec. 2023 (kr180.76 Mil) to Mar. 2024 (kr180.76 Mil).

Dicot AB's annual additional paid-in capital increased from Dec. 2021 (kr81.67 Mil) to Dec. 2022 (kr86.15 Mil) and increased from Dec. 2022 (kr86.15 Mil) to Dec. 2023 (kr180.76 Mil).

Dicot AB Additional Paid-In Capital Historical Data

The historical data trend for Dicot AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB Additional Paid-In Capital Chart

Dicot AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

32.22

53.21

81.67

86.15

180.76

Dicot AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															134.99	166.65	166.52	180.76	180.76

Dicot AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Dicot AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Dicot AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Dicot AB (XSAT:DICOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (XSAT:DICOT) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

KN0:Germany

Address

Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37

Website

http://www.dicot.se

Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (XSAT:DICOT) Headlines

No Headlines